5-43297096-T-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS1

The NM_001098272.3(HMGCS1):​c.645A>G​(p.Ile215Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000027 ( 0 hom. )

Consequence

HMGCS1
NM_001098272.3 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.448
Variant links:
Genes affected
HMGCS1 (HGNC:5007): (3-hydroxy-3-methylglutaryl-CoA synthase 1) Enables protein homodimerization activity. Predicted to be involved in acetyl-CoA metabolic process and farnesyl diphosphate biosynthetic process, mevalonate pathway. Predicted to be located in cytoplasm. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19876993).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000046 (7/152224) while in subpopulation AFR AF= 0.000169 (7/41466). AF 95% confidence interval is 0.0000789. There are 0 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HMGCS1NM_001098272.3 linkc.645A>G p.Ile215Met missense_variant Exon 5 of 11 ENST00000325110.11 NP_001091742.1 Q01581A0A024R059

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HMGCS1ENST00000325110.11 linkc.645A>G p.Ile215Met missense_variant Exon 5 of 11 1 NM_001098272.3 ENSP00000322706.6 Q01581
HMGCS1ENST00000433297.2 linkc.645A>G p.Ile215Met missense_variant Exon 4 of 10 5 ENSP00000399402.2 Q01581

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461132
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
726914
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152224
Hom.:
0
Cov.:
32
AF XY:
0.0000807
AC XY:
6
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 21, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.645A>G (p.I215M) alteration is located in exon 5 (coding exon 3) of the HMGCS1 gene. This alteration results from a A to G substitution at nucleotide position 645, causing the isoleucine (I) at amino acid position 215 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.42
T;T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.41
N
LIST_S2
Uncertain
0.88
.;D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.20
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.66
N;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.21
Sift
Uncertain
0.029
D;D
Sift4G
Uncertain
0.054
T;T
Polyphen
0.0010
B;B
Vest4
0.19
MutPred
0.62
Loss of catalytic residue at I215 (P = 0.0828);Loss of catalytic residue at I215 (P = 0.0828);
MVP
0.25
MPC
0.99
ClinPred
0.24
T
GERP RS
0.82
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1478056967; hg19: chr5-43297198; API